Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04424017
NCT04424017
Completed
Not Applicable

Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers

Egyptian Center for Research and Regenerative Medicine2 sites in 1 country1,546 target enrollmentJune 7, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOVIDCorona Virus Infection

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID
Sponsor
Egyptian Center for Research and Regenerative Medicine
Enrollment
1546
Locations
2
Primary Endpoint
Describe the serological status of individuals in the study by presence of specific anti-SARS-CoV-2 antibodies
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The medical and paramedical staff of the front-line services are potentially exposed to SARS-CoV-2. Therefore, despite the application of standard protective measures, it is possible that a certain number of these personnel have already contracted SARS-CoV-2, including in its asymptomatic form. Serological testing in this context would be useful for deploying immune healthcare workers as to limit the risk of viral infection and transmission. Therefore, it is of utmost importance to prove that the serological response entails the production of neutralizing antibodies.

Registry
clinicaltrials.gov
Start Date
June 7, 2020
End Date
October 30, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Not previously diagnosed with COVID-19 except for convalescents
  • •Not currently symptomatic with fever or respiratory symptoms (cough, dyspnea)

Exclusion Criteria

  • •Patients with fever or respiratory symptoms (cough, dyspnea)
  • •Refusal to give informed consent, or contraindication to venipuncture.

Outcomes

Primary Outcomes

Describe the serological status of individuals in the study by presence of specific anti-SARS-CoV-2 antibodies

Time Frame: 3 Months

Study Sites (2)

Loading locations...

Similar Trials

Unknown
Not Applicable
Professional's Health in Epidemiological Crisis Covid-19COVID-19SARS-CoV-2
NCT04885478Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina1,350
Recruiting
Not Applicable
ARMOR Study: COVID-19 Seroprevalence Among Healthcare WorkersCovid-19Coronavirus InfectionCoronavirus
NCT04367857Columbia University1,000
Completed
Not Applicable
Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.COVID-19
NCT04488484Fondation Hôpital Saint-Joseph80
Completed
Not Applicable
Health Professional Exposure Assessment to Covid-19COVID-19
NCT04429724Tourcoing Hospital2,129
Unknown
Not Applicable
COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 SectorInfection Viral
NCT04481529University Hospital, Limoges1,576